Cancer stem cell activity of copper( ii )-terpyridine complexes with aryl sulfonamide groups
Dalton Transactions · 2023 · 52 (28) · 9694-9704
DOI: 10.1039/d3dt01294h ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2023. Verfasst von Karampal Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Leicester, Leicester LE1 7RH, UK. k.suntharalingam@leicester.ac.uk. Hauptthemen laut MEDLINE: Coordination Complexes, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: University of Leicester, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Here we report the synthesis, characterisation, and anti-breast cancer stem cell properties of a series of copper( ii )-terpyridine complexes containing aryl sulfonamide groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, University of Leicester, Leicester LE1 7RH, UK. k.suntharalingam@leicester.ac.uk.
Förderung
- University of Leicester
- Engineering and Physical Sciences Research Council
Zitieren
APA
Singh, K., Northcote-Smith, J., Singh, K., & Suntharalingam, K. (2023). Cancer stem cell activity of copper( ii )-terpyridine complexes with aryl sulfonamide groups. Dalton Transactions, 52(28), 9694-9704. https://doi.org/10.1039/d3dt01294h
Vancouver
Singh K, Northcote-Smith J, Singh K, Suntharalingam K. Cancer stem cell activity of copper( ii )-terpyridine complexes with aryl sulfonamide groups. Dalton Transactions. 2023;52(28):9694-9704. doi:10.1039/d3dt01294h
BibTeX
@article{Singh2023,
author = {Singh, Karampal and Northcote-Smith, Joshua and Singh, Kuldip and Suntharalingam, Kogularamanan},
title = {Cancer stem cell activity of copper( ii )-terpyridine complexes with aryl sulfonamide groups},
journal = {Dalton Transactions},
year = {2023},
volume = {52},
number = {28},
pages = {9694--9704},
doi = {10.1039/d3dt01294h}
}
EUVIMED